The SUMMIT study assesses tirzepatides impact on HF with HFpEF in obese patients
According to FDA prescribing information, gastrointestinal side effects are typically most pronounced during dose initiation and escalation, and they often diminish over time as the body adapts to the medication
Discuss individual risk factors with your provider to evaluate whether GLP-1 aligns with your health plan
Some patients may continue medication long term, some may adjust the dose, and others may transition to a different maintenance plan
We are here to support you on your weight management journey and help you achieve long-lasting success
Suliman M, Buckley A, Al Tikriti A, Tan T, le Roux CW, Lessan N, et al